🗞️ Léopold nous gratifie d'un nouvel article d'opinion pour alerter les jeunes chercheurs sur certaines mauvaises pratiques un peu trop ancrées dans les meurs des labo de recherches 🚩 :
https://t.co/wGbaAuhUOW
#bioinfofr#bioinformatique#prevention#opinion
Il reste quelques places pour le Webinaire de ce mardi 12/11 à 18h donné par Dr Sylvie DOLBEAULT @institut_curie sur la peur de la récidive en oncologie : modèles cliniques, facteurs de risque et modalités d’intervention psychothérapeutique
Inscription : https://t.co/MHygm7KGfo
Les 20èmes Journées Annuelles du Cancéropôle GSO se dérouleront à Perpignan du 20 au 22 novembre
📢 J-2 pour vous inscrire 🗓
Plus d'infos: https://t.co/E9idptgreG #JGSO#Cancer@institut_cancer
@yvCBiXbpd4eXVOu had the opportunity to present her work at the 2nd young scientist cancer congress in Montpellier.
A wonderful presentation where she showed her work on Vps34 and Reg proteins in pancreas!
#YS2C2024
#YS2C was a big success! It's hard to put in words. The general feedback of the attendees: a conference with a relaxed ambiance and great science under the gorgeous sun of #Montpellier . I second that! 👍
Thank you for participating and we hope to see you soon again 😉
Do you like to mix science and boosting your career in a nice ambiance with great French food and sunny weather? Then use the last chance to 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐟𝐨𝐫 𝐭𝐡𝐞 𝟐𝐧𝐝 𝐘𝐨𝐮𝐧𝐠 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐂𝐨𝐧𝐠𝐫𝐞𝐬𝐬. 🌞
https://t.co/GVra9e5M41
#YS2C
Last day to submit an abstract to the 2nd Young Scientist Cancer Congress (#YS2C).
YS2C will take place at Montpellier October 10 & 11. #postdocs and #clinicians from #Montpellier, #Bordeaux, #Toulouse, and #Berlin organize the YS2C. Follow the thread below. 1/7
Very proud to share with you our latest work published in Nature Communications which highlights the critical role of farnesyl transferase inhibition in preventing #resistance to #targetedtherapies in #NSCLC. https://t.co/Mxt6SYBlN5
Fred Pont from the CRCT platform presented his poster “Single-cell spatial explorer: easy exploration of spatial and multimodal transcriptomics.” Congratulations Fred!